These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6161820)

  • 1. Relationship between prostatic cytoplasmic and nuclear androgen receptors in patients with carcinoma of the prostate.
    Ghanadian R; Auf G; Williams G
    Eur Urol; 1981; 7(1):39-40. PubMed ID: 6161820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor content of the normal and hyperplastic canine prostate.
    Shain SA; Boesel RW
    J Clin Invest; 1978 Mar; 61(3):654-60. PubMed ID: 76635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
    Barrack ER; Bujnovszky P; Walsh PC
    Cancer Res; 1983 Mar; 43(3):1107-16. PubMed ID: 6186370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the association between blood prolactin and androgen receptors in BPH.
    Odoma S; Chisholm GD; Nicol K; Habib FK
    J Urol; 1985 Apr; 133(4):717-20. PubMed ID: 2580105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic and nuclear androgen receptor content of normal and neoplastic human prostates and lymph node metastases of human prostatic adenocarcinoma.
    Shain SA; Boesel RW; Lamm DL; Radwin HM
    J Clin Endocrinol Metab; 1980 Apr; 50(4):704-11. PubMed ID: 6154061
    [No Abstract]   [Full Text] [Related]  

  • 7. Inability of cytoplasmic or nuclear androgen receptor content or distribution to distinguish benign from carcinomatous human prostate.
    Shain SA; Gorelic LS; Klipper RW; Ramzy I; Novicki DE; Radwin HM; Lamm DL
    Cancer Res; 1983 Aug; 43(8):3691-5. PubMed ID: 6861139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of estrogen and androgen receptor status in prostatic disease measured by high pressure liquid chromatography.
    Kirdani RY; Pontes EJ; Murphy GP; Sandberg AA
    J Steroid Biochem; 1984 Jan; 20(1):401-6. PubMed ID: 6200699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear androgen receptor assay in biopsy-size specimens of human prostatic tissue.
    Blankenstein MA; Bolt-de Vries J; Foekens JA
    Prostate; 1982; 3(4):351-9. PubMed ID: 7122332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of methyltrienolone in the measurement of the free and bound cytoplasmic receptors for dihydrotestosterone in benign hypertrophied human prostate.
    Ghanadian R; Auf G; Chaloner PJ; Chisholm GD
    J Steroid Biochem; 1978 Apr; 9(4):325-30. PubMed ID: 77939
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytoplasmic and nuclear androgen receptors of human prostate.
    Shain SA; Boesel RW; Radwin HM; Lamm DL
    Prog Clin Biol Res; 1979; 33():33-49. PubMed ID: 93751
    [No Abstract]   [Full Text] [Related]  

  • 12. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
    Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
    Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
    [No Abstract]   [Full Text] [Related]  

  • 13. Androgen receptor assay in human benign and malignant prostatic tumour cytosol using protamine sulphate precipitation.
    Mobbs BG; Johnson IE; Connolly JG; Clark AF
    J Steroid Biochem; 1978 Apr; 9(4):289-301. PubMed ID: 77938
    [No Abstract]   [Full Text] [Related]  

  • 14. Assay of nuclear androgen receptor in human prostate.
    Lieskovsky G; Bruchovsky N
    J Urol; 1979 Jan; 121(1):54-8. PubMed ID: 83397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
    Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
    Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid hormone receptors in prostatic hyperplasia and prostatic carcinoma.
    Khalid BA; Nurshireen A; Rashidah M; Zainal BY; Roslan BA; Mahamooth Z
    Med J Malaysia; 1990 Jun; 45(2):148-53. PubMed ID: 1725553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of androgen receptors in the human prostate by isoelectric focussing in polyacrylamide gel.
    Auf G; Ghanadian R
    J Steroid Biochem; 1981 Dec; 14(12):1261-7. PubMed ID: 6173513
    [No Abstract]   [Full Text] [Related]  

  • 18. Androgen receptor binding activity in human prostate cancer.
    Benson RC; Utz DC; Holicky E; Veneziale CM
    Cancer; 1985 Jan; 55(2):382-8. PubMed ID: 2578085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear androgen receptors of human prostatic tissue--a quantitative histological study.
    Elhilali M; Lehoux JG; Carmel M; Madarnas P; Mongeau C; Beauchesne C; Tétreault L; Bénard B
    Arch Androl; 1983 Mar; 10(1):21-7. PubMed ID: 6189463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostatic cytoplasmic androgen receptor in prostatic disease. I. Serum androgen levels, cytoplasmic androgen levels and cytoplasmic R1881 receptor in prostatic disease].
    Kitano T
    Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1084-97. PubMed ID: 6334192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.